Hi [[ session.user.profile.firstName ]]

Forensic Science

  • How to publish in groundbreaking journals
    How to publish in groundbreaking journals
    Steve W. Cranford, Editor-in-Chief, Matter Recorded: Nov 26 2020 87 mins
    Would you like to learn tips for writing and developing a strong narrative for your work? Do you want advice on how to prepare your manuscripts for publication in the best journal for your research? Join us for a webinar with Steve W. Cranford, Editor-in-Chief, Matter to learn techniques and strategies to set yourself up for publishing success. Dr. Cranford will share details about the growth of multidisciplinary Cell Press journals and tips on developing your manuscript and will elaborate on his experience working with researchers throughout the publishing cycle. Join this engaging webinar and get answers to your questions in the Q&A session. Don’t forget to extend this invitation to your colleagues who might find this of interest.

    About Steve W. Cranford:
    A graduate from Memorial University (Canada), Stanford University (USA), and Massachusetts Institute of Technology (USA), Dr. Cranford was faculty at Northeastern University’s College of Engineering prior to accepting a new role as editor-in-chief for Matter.
    He has over 50 publications in the field of materials science in a range of high-impact journals, including Nature and Advanced Materials, with expertise in the area of atomistic simulation, computational modeling, and nanomechanics, encompassing a variety of materials systems, from carbyne to copper to concrete.
    He would have preferred to have published in Matter, but it didn’t exist. He constantly played with LEGO blocks as a child, likely leading to his interest in material assembly and structure.

    About the journal Matter:
    Matter, a sister journal to Cell, is a monthly journal encompassing the general field of materials science, from nano to macro and fundamentals to application. Recognizing that materials discovery and development facilitate groundbreaking technologies bridging multiple disciplines, Matter will embrace all significant advances in materials research, encompassing the previously unknown and the innovative.
  • A Technical Blueprint for Data Protection
    A Technical Blueprint for Data Protection
    Ankur Chadda, Principal Data Protection Solutions Manager & Robert Mechler, Principal Security Strategist, Forcepoint Recorded: Nov 25 2020 36 mins
    Running a successful data protection program is not as simple as plug-in, configure and go – it requires careful planning and execution if you are to realize its full potential.

    In this webcast, Principal Data Protection Solutions Manager Ankur Chadda is joined by Principal Security Strategist Bob Mechler to discuss a 9-Step Strategy for Success.

    Key learnings include:

    - How the move to cloud is making data protection harder
    - How to identify where your critical data is, the channels it flows through and establish an incident response plan
    - How to move from passive data monitoring to implementing policy controls – that don’t impact productivity
    - How a comprehensive understanding of risk can help you shift from a reactive to proactive posture to stop breaches before they happen
  • Raw Material Sourcing and Qualification
    Raw Material Sourcing and Qualification
    Scott R. Burger, MD, Principal of Advanced Cell & Gene Therapy, LLC Recorded: Nov 23 2020 65 mins
    Effective raw materials sourcing, testing, qualification and control are critical for product safety and quality to assure lot-to-lot consistency and functional activity in the manufacturing process. This is more challenging for biological raw materials, such as enzymes, sera, and cytokines, which often cannot be fully defined by testing, and may present risks related to animal or human source, or country of origin. These points can be addressed by sourcing and qualifying materials based on an evaluation of potential risk and desired functional characteristics, and defining supplier requirements, testing, specifications, and other control mechanisms accordingly. Raw material qualification becomes increasingly rigorous and comprehensive as clinical development progresses. This webinar will identify critical concerns, clarify regulatory requirements and outline how to develop robust systems for managing and qualifying raw materials.
  • Cell Press Publishing Overview & Researcher Resources
    Cell Press Publishing Overview & Researcher Resources
    Head of Strategy and Partnership in Greater China, Cell Press/Senior Scientific Editor, Cell Recorded: Nov 21 2020 54 mins
    Learn all about innovation, growth in the multi-disciplinary content and the expanding open access publishing strategy at Cell Press with Dr. Jiaying Tan, Head of Strategy and Partnership in Greater China and Cell Press Senior Scientific Editor at Cell.

    You can expect to learn more about the community outreach programs at Cell Press like webinars, symposia, Cell Mentor, Sneak Peek, STAR Methods, STAR Protocols and much more which can help your researchers as well as institutes to grow faster and deliver a higher impact in the world.

    We promise to make the webinar engaging and to answer all your questions around Cell Press. At Cell Press, everything we do aims to drive research forward — whether it's working with authors, enhancing the peer review process, or developing innovations in publishing. We put science first, science that people talk about.

    Join Dr. Tan in this engaging webinar and make sure to bring along your colleague and friends who may benefit from these helpful resources.
  • New Trends and Future Directions in Catalysis
    New Trends and Future Directions in Catalysis
    Frances Arnold, Lutz Ackermann, Corinna Schindler, and Douglas W. Stephan Recorded: Nov 21 2020 107 mins
    The field of catalysis in chemistry was historically dominated by the use of transition metal catalysts. Due to a unique set of properties, precious metals in particular have played an integral role in developing catalysts for new modes of chemical bond activation and formation. One major and inherent drawback of precious metals, however, is their scarcity; in order to transition chemistry to a more sustainable use of the world’s limited resources, finding alternative strategies for catalysis is a major driving force in contemporary research. In this spirit, this webinar will feature talks about four areas of sustainable catalysis from leaders in their respective fields, highlighting state-of-the-art approaches and providing guidance for future developments in these areas of research.

    Speaker Information:

    Frances Arnold is Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry, and Director of the Donna and Benjamin M. Rosen Bioengineering Center at Caltech. She received the Nobel Prize in Chemistry in 2018 for directed enzyme evolution.

    Lutz Ackermann is a Professor at the Georg-August-University Göttingen. The development and application of novel concepts for sustainable catalysis constitutes his major current research interest, and he has a topical focus on C–H activation.

    Corinna Schindler is an Associate Professor at the University of Michigan. The research interests of her laboratory include the synthesis of complex molecules and the development of new synthetic transformations between carbonyls and alkenes.

    Douglas W. Stephan is a Professor at the University of Toronto and a world-leading researcher in inorganic chemistry/catalysis and the founder of the field of “frustrated Lewis pair” (FLP) chemistry. He has received many national and international awards, including Humboldt and Killam Fellowships.
  • Essential tips for publishing in high-impact journals
    Essential tips for publishing in high-impact journals
    Dr. Rose Zhu, Associate Scientific Editor, Joule Recorded: Nov 20 2020 71 mins
    Discover the best techniques and strategies for authoring in high impact journals with Dr. Rose Zhu, Associate Scientific Editor at Joule (Cell Press journal). You can expect to learn:
    •Techniques and strategies for improving the scientific writing process including tips on writing a better introduction, creating an effective abstract and analysing the results in your research paper
    •Tactics on developing papers for premium publications (also tips focused on researchers based in China)
    •Exploring the opportunities to broadly disseminate findings
    •Discover the Cell Press physical science portfolio of journals including newly launched titles such as Chem, Joule, Matter & One Earth

    Dr. Zhu will also outline Cell Press’ approach to high-demand, multi-disciplinary content, and expanding OA publishing strategies at Cell Press.

    Sign up for this interesting free webinar and learn best tips & tricks to benefit your research process and increase your research impact.

    Bring along a friend or colleague who might be instrumental in improving your research paper.

    Here’s a quick introduction about Dr. Rose Zhu:
    Dr. Rose Zhu joined Joule as Associate Scientific Editor in 2017 and is based in the Shanghai office. Since 2017, Dr. Zhu has given over 100 talks on scientific writing and publishing techniques with Joule and other Cell Press physical science journals. Dr. Zhu completed her Ph.D. from Nanyang Technological University (NTU, Singapore) after completing the BSc degree at Sichuan University (China). Dr. Zhu has published 10+ papers in the physical sciences field covering wide array of topics like Nano energy, material horizon and much more.
  • Authoring in The Lancet — Learn from the Editors!
    Authoring in The Lancet — Learn from the Editors!
    John McConnell, Editor-in-Chief of The Lancet Infectious Diseases Recorded: Nov 20 2020 76 mins
    Join John McConnell, Editor-in-Chief of The Lancet Infectious Diseases to learn about techniques and strategies for authoring in high-impact journals. Mr. McConnell will present his experience working with researchers and authors throughout the research publishing cycle. You will learn how to develop papers for premium publications, and how to broadly disseminate findings. Do not miss this engaging webinar, join and ask any questions that you feel will benefit your research!
  • How to publish with the Journal of Thoracic Oncology
    How to publish with the Journal of Thoracic Oncology
    Dr. Alex Adjei, Editor-in-Chief, Journal of Thoracic Oncology Recorded: Nov 19 2020 88 mins
    Finding the right journal to publish your research and structuring your research to publish in high impact journals can be a challenge. Learn techniques and strategies to publish in high impact journals like the Journal of Thoracic Oncology with Dr. Alex Adjei, Editor-in-Chief.

    You can expect to learn about:
    -Manuscript preparation tips
    -Features of successful manuscripts
    -Fatal errors in manuscripts that lead to outright rejection
    -The editorial process
    -How to publish in JTO and its new spin-off JTO Clinical Research Reports
    -New initiatives at the Journal

    About Dr. Alex Adjei:
    Alex A. Adjei is a Professor of Oncology and Professor of Pharmacology in the Mayo College of Medicine. He is also a consultant in Medical Oncology at Mayo Clinic. Dr. Adjei is Director of the Early Cancer Therapeutics Program across all three Mayo Clinic sites, and leader of the Lung Cancer Program across all 3 Mayo Clinic sites. He is the Principal Investigator of the Mayo Phase I and Phase II NCI grants. Dr Adjei has served on a number of National Cancer Institute (US) Committees. He is currently co-chair of the Thoracic Malignancies Steering Committee. Dr Adjei is a past member of the IASLC Board of Directors. He is the Editor-in-Chief of the Journal of Thoracic Oncology and the inaugural Editor-in-Chief of JTO Clinical and Research Reports. Dr. Adjei’s research is focused on experimental therapeutics and clinical drug development. He received the first ASCO Drug Development Research Professorship 2012-2017, in recognition of his mentorship and his work in cancer drug development. He has authored 280 publications dealing primarily with preclinical pharmacology and phase I trials as well as novel therapeutics/phase II trials of lung cancer.
  • How to Become a Successful Researcher At Every Stage of Your Career
    How to Become a Successful Researcher At Every Stage of Your Career
    Dr. Valentin Fuster, Editor-in-Chief, JACC & Dr. Harlan Krumholz, Cardiologist & Health Care Researcher at Yale University Recorded: Nov 19 2020 90 mins
    Pursuing a career as a physician-scientist can be daunting, especially as the success rates for securing research grants has declined from 33% to 19%, while the number of grant applications has increased by 72%. However, the pathway can provide personal and professional fulfillment and dynamism, if the individual is equipped with a roadmap for success. Valentin Fuster, MD, PhD, MACC, editor in chief of the Journal of the American College of Cardiology (JACC), and Harlan M. Krumholz, MD, SM, FACC, director of the Yale Center for Outcomes Research and Evaluation at Yale School of Medicine, will discuss how to maintain a successful physician-scientist career at three stages: early career, mid-career and senior. They will include tips for grant receipts, the importance of the mentee/mentorship relationship, and the need for creativity in grant submissions. In addition, viewers will have the opportunity to ask these thought leaders questions and pointers.

    About the presenters:
    Dr. Valentin Fuster serves The Mount Sinai Hospital as Physician-in-Chief, as well as Director of Mount Sinai Heart, the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health. He is also the Richard Gorlin, MD/Heart Research Foundation Professor, Icahn School of Medicine at Mount Sinai.

    Dr. Harlan Krumholz is a cardiologist and health care researcher at Yale University and Yale New Haven Hospital. He also serves as Director of the Yale Center for Outcomes Research and Evaluation (CORE) at Yale School of Medicine.

    Learn more about the JACC family of journals at JACC.org.
  • How to publish with Nursing for Women's Health
    How to publish with Nursing for Women's Health
    Dr. Mary C. Brucker, Editor, Nursing for Women's Health Recorded: Nov 19 2020 46 mins
    Learn techniques and strategies to publish in Nursing for Women’s Health with editor Dr. Mary C. Brucker. You can expect to learn about developing a manuscript, strategies for getting your work accepted, and common reasons for rejection. During this webinar, Mary will elaborate on what sets Nursing for Women’s Health apart from other journals in this field and the reasons to submit your work to this premium journal. Join this engaging webinar and get an opportunity to also find answers to your questions in the Q&A session during the webinar. You can submit your questions via this link: https://smittalsachdeva.typeform.com/to/lpeD05 and we will aim to answer your questions during the webinar.

    Don’t forget to extend this invitation to your colleagues who might find this of interest.

    About Nursing for Women’s Health:
    Nursing for Women's Health (NWH) is an official journal of the Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN). The mission of NWH is to improve outcomes for women and newborns through the dissemination of clinical scholarship. The journal focuses on evidence-based practice for women's health, childbearing, and neonatal care. The tone of NWH is practical and reader-friendly while upholding high standards for scholarly content.
    NWH publishes a variety of manuscript types, including original research with a clinical focus, reviews, quality improvement projects, practice articles, case reports, continuing nursing education (CNE) articles, health care policy, legislative, or advocacy articles, commentaries, personal essays, and letters to the editor.
  • Must Know Tips for Publishing In JACC Journals
    Must Know Tips for Publishing In JACC Journals
    Dr. David J. Moliterno, Editor-in-Chief, JACC Cardiovascular Interventions Recorded: Nov 18 2020 75 mins
    Learn techniques and strategies for getting published in JACC journals with Dr. David J. Moliterno, MD, FACC, Editor-in-Chief, JACC: Cardiovascular Interventions. Dr. Moliterno will present information on publishing in JACC Journals. Dr. Moliterno will share his expertise in working with researchers and authors throughout the research publishing cycle, how to develop papers for premium publications, and the opportunity to broadly disseminate findings. One of eight JACC Journals published by the American College of Cardiology (ACC), JACC: Cardiovascular Interventions disseminated top science in interventional cardiovascular medicine, including coronary, structural, peripheral and cerebrovascular diseases. You won’t want to miss this engaging webinar and how it can benefit your research process and impact. Learn about submitting to JACC Journals and subscribe to eTable of Content emails.

    About Dr. David J. Moliterno
    Dr. Moliterno is the Editor-in-Chief of JACC: Cardiovascular Interventions. He is the Jack M. Gill Chair and Professor of the Department of Internal Medicine at the University of Kentucky. He is also a member of the interventional cardiology faculty at the Gill Heart and Vascular Institute in Lexington, Kentucky. He has been involved with numerous investigational studies in cardiovascular medicine over the last two decades, with his primary research interest being in acute coronary syndromes. Prior to assuming position as Editor-in-Chief, Dr. Moliterno served as an associate editor for the journal. An active member of the ACC, Dr. Moliterno has been a member of the Board of Governors, Strategic Education Committee, and the Interventional Section Leadership Council.
  • Emerging technologies and clinical research in Latin America
    Emerging technologies and clinical research in Latin America
    David Collingridge,Carlos Barrios,Eduado Cazap,Gustavo Werutsky,Georgina Sposetti,Rodrigo Dienstmann & Stephen Stephani Recorded: Nov 18 2020 120 mins
    Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries. In 2013 and 2015, The Lancet Oncology published two Commissions that highlighted the cancer landscape in Latin America and how it differed from more developed countries. The reports showed that funding for health care was just a small percentage of national gross domestic product and the percentage of health-care funds diverted to cancer care was even lower. Funding, insurance coverage, numbers of doctors, health-care workers, resources, and equipment were inequitably distributed between and within Latin American countries. The Commissions emphasised the need for structural reforms in health-care systems, the need for dedicated cancer control programmes for disenfranchised populations, the importance of expanding coverage of cancer registries and cancer plans, and the effect of implementing policies to improve primary cancer prevention. In this webinar, renowned experts from Brazil, Argentina, and Spain, revisit cancer control in Latin America via a more contemporaneous lens, with a focus on the challenges surrounding academic research funding, clinical trial recruitment, big data, and wider access to the latest diagnostic technologies.
  • Sustainable care for children with cancer: a Lancet Oncology Commission
    Sustainable care for children with cancer: a Lancet Oncology Commission
    Ali Landman, Carlos Rodriguez-Galindo, Kathy Pritchard-Jones, Rifat Atun Recorded: Nov 18 2020 116 mins
    Cancer kills more than 100,000 children each year, and yet 80% of pediatric cancers are curable with currently available interventions. Notably, the majority of these deaths occur in low‐income and middle-income countries. Yet no reliable data are available in low-income and middle-income countries on the burden of childhood cancer; on the cost of effective interventions; on current health coverage levels; or on the cost, feasibility, or health and economic benefits of scaling-up effective coverage.

    In March, 2020, The Lancet Oncology published a Commission on Sustainable care for children with cancer, which provided a new analysis of the global childhood cancer burden and developed an economic investment case and evidence-based medical framework for implementing, integrating, and scaling up care pathways for childhood cancer.

    Join Dr. Ali Landman, Deputy Editor of The Lancet Oncology, and Commission authors, as they discuss the aims, findings, and recommendations from the Commission.
  • Learn how Lancet editors decide which papers to accept for publication
    Learn how Lancet editors decide which papers to accept for publication
    Heather Van Epps, Editor-in-Chief The Lancet Rheumatology Recorded: Nov 17 2020 69 mins
    Join Heather Van Epps, Editor-in-Chief of The Lancet Rheumatology, to learn about techniques and strategies for preparing your paper to submit to high-impact journals.

    Heather will share her experiences working with researchers and authors throughout the research publishing cycle. You will learn how to develop papers for submission to publications like the Lancet family of journals.

    Do not miss this engaging webinar―you are invited to join and ask any questions that you feel will benefit your research.

    Don't forget to download your manuscript checklist from the resources section.
  • How to publish in groundbreaking journals
    How to publish in groundbreaking journals
    Steve W. Cranford, Editor-in-Chief, Matter Recorded: Nov 17 2020 87 mins
    Would you like to learn tips for writing and developing a strong narrative for your work? Do you want advice on how to prepare your manuscripts for publication in the best journal for your research? Join us for a webinar with Steve W. Cranford, Editor-in-Chief, Matter to learn techniques and strategies to set yourself up for publishing success. Dr. Cranford will share details about the growth of multidisciplinary Cell Press journals and tips on developing your manuscript and will elaborate on his experience working with researchers throughout the publishing cycle. Join this engaging webinar and get answers to your questions in the Q&A session. Don’t forget to extend this invitation to your colleagues who might find this of interest.

    About Steve W. Cranford:
    A graduate from Memorial University (Canada), Stanford University (USA), and Massachusetts Institute of Technology (USA), Dr. Cranford was faculty at Northeastern University’s College of Engineering prior to accepting a new role as editor-in-chief for Matter.
    He has over 50 publications in the field of materials science in a range of high-impact journals, including Nature and Advanced Materials, with expertise in the area of atomistic simulation, computational modeling, and nanomechanics, encompassing a variety of materials systems, from carbyne to copper to concrete.
    He would have preferred to have published in Matter, but it didn’t exist. He constantly played with LEGO blocks as a child, likely leading to his interest in material assembly and structure.

    About the journal Matter:
    Matter, a sister journal to Cell, is a monthly journal encompassing the general field of materials science, from nano to macro and fundamentals to application. Recognizing that materials discovery and development facilitate groundbreaking technologies bridging multiple disciplines, Matter will embrace all significant advances in materials research, encompassing the previously unknown and the innovative.
  • How to Prepare Your Manuscripts for Publication in Top Journals
    How to Prepare Your Manuscripts for Publication in Top Journals
    Kavitha Scranton, Ph.D., Senior Scientific Editor, Immunity (Cell Press) Recorded: Nov 17 2020 78 mins
    Would you like to learn tips for writing and developing a strong narrative for your work? Do you want advice on how to prepare your manuscripts for publication in the best journal for your research? Join us for a webinar with Kavitha Scranton, Ph.D., Senior Scientific Editor at Immunity (Cell Press) to learn techniques and strategies to set yourself up for publishing success. Kavitha will share tips on developing your manuscript (with a special focus on researchers based in the Turkey/ME region), elaborate on her experience working with researchers throughout the publishing cycle, and highlight opportunities to broadly disseminate your research findings. Kavitha will also share more details about the growth of multidisciplinary Cell Press journals. Join this engaging webinar and get answers to your questions in the Q&A session. Don’t forget to extend this invitation to your colleagues who might find this of interest.

    About Kavitha Scranton:
    Kavitha Scranton received her Ph.D. in Immunology from the University of Massachusetts Medical School, where she studied the development and function of γδ T cells in the laboratory of Dr. Joonsoo Kang. She conducted her postdoctoral research at the Broad Institute of MIT and Harvard on T cell-mediated autoimmunity in the laboratory of Dr. Ramnik Xavier. In 2015, Kavitha joined Immunity as a scientific editor.
  • How to Prepare Your Manuscripts for Publication in Top Journals
    How to Prepare Your Manuscripts for Publication in Top Journals
    Kavitha Scranton, Ph.D., Senior Scientific Editor, Immunity (Cell Press) Recorded: Nov 16 2020 78 mins
    Would you like to learn tips for writing and developing a strong narrative for your work? Do you want advice on how to prepare your manuscripts for publication in the best journal for your research? Join us for a webinar with Kavitha Scranton, Ph.D., Senior Scientific Editor at Immunity (Cell Press) to learn techniques and strategies to set yourself up for publishing success. Kavitha will share tips on developing your manuscript (with a special focus on researchers based in the Turkey/ME region), elaborate on her experience working with researchers throughout the publishing cycle, and highlight opportunities to broadly disseminate your research findings. Kavitha will also share more details about the growth of multidisciplinary Cell Press journals. Join this engaging webinar and get answers to your questions in the Q&A session. Don’t forget to extend this invitation to your colleagues who might find this of interest.

    About Kavitha Scranton:
    Kavitha Scranton received her Ph.D. in Immunology from the University of Massachusetts Medical School, where she studied the development and function of γδ T cells in the laboratory of Dr. Joonsoo Kang. She conducted her postdoctoral research at the Broad Institute of MIT and Harvard on T cell-mediated autoimmunity in the laboratory of Dr. Ramnik Xavier. In 2015, Kavitha joined Immunity as a scientific editor.
  • Best Practices in Submitting Research for Highly Selective Journals
    Best Practices in Submitting Research for Highly Selective Journals
    Dr. Robert D. Eagling, Editor-in-Chief of Chem (Cell Press journal) Recorded: Nov 16 2020 76 mins
    Learn techniques and strategies for publishing strategies to give you the best chance of successfully publishing in highly selective journals with Dr. Robert D. Eagling, editor-in-chief of Chem (a Cell Press journal). Dr. Eagling will share tips on developing your papers for premium publications (with special focus on researchers based in the Eastern Europe region), elaborate on his experience of working with researchers and authors throughout the research publishing cycle and discuss the opportunity to broadly disseminate findings. Dr. Eagling will also share more details about the growth of Cell Press journals in the physical sciences field. Such details will include the launch of many new titles, such as Chem, Matter, Joule, and One Earth. He’ll also outline Cell Press’s approach to high-demand, multi-disciplinary content and expanding OA publishing strategies at Cell Press. Join this engaging webinar and ask any remaining questions in the Q&A session. Don’t forget to extend this invitation to your colleagues who might find this of interest.

    About Robert Eagling:
    Robert Eagling, Ph.D., is a graduate of Newcastle University in England and brings to Chem around 15 years of experience in chemistry publishing. He came to Cell Press from the Royal Society for Chemistry (RSC), where he helped grow submissions and readership of Chemical Communications, increased the visibility and impact of Chemical Society Reviews in 10 years from 13 to 34, and led the launch of Chemical Science, the RSC’s flagship general chemistry journal with Professor David McMillan as the inaugural Editorial Board Chairman.
  • Smart machine learning solution to master industry 4.0 in biopharma
    Smart machine learning solution to master industry 4.0 in biopharma
    Moritz von Stosch, PhD Recorded: Nov 11 2020 42 mins
    In the biopharmaceutical industry the utilization of miniaturized and parallelized high throughput techniques, continuous bioprocessing and continuous data acquisition as well as the utilization of data- and knowledge-driven tools for process analysis, forecasting, monitoring, control and digital twin creation are now becoming more common. In order to eventually enter fully in the industry 4.0 era, these methodologies and technologies must be further developed so that they can be fully rolled-out across the biopharmaceutical process industry.

    Throughout the past years, several digital solutions for the analysis, modelling and interpretation of cell culture processes based on advanced engineering statistics, hybrid modelling approaches and advanced spectral data processing methods have emerged. We show how they can successfully be integrated into upstream and downstream process development workflows in several collaboration projects with the biopharmaceutical industry. Based on these industrial collaborations we will share our insights into central challenges in digitalization and data analytics in biopharma. We will demonstrate the potential to provide systematically technological and business value through integration of smart technologies as digital twins into the work stream of upstream and downstream development and tech transfer.
  • Authoring in The Lancet — Learn from the Editors!
    Authoring in The Lancet — Learn from the Editors!
    John McConnell, Editor-in-Chief of The Lancet Infectious Diseases Recorded: Nov 10 2020 76 mins
    Join John McConnell, Editor-in-Chief of The Lancet Infectious Diseases to learn about techniques and strategies for authoring in high-impact journals. Mr. McConnell will present his experience working with researchers and authors throughout the research publishing cycle. You will learn how to develop papers for premium publications, and how to broadly disseminate findings. Do not miss this engaging webinar, join and ask any questions that you feel will benefit your research!
  • Designer Sterile Filtration in Aseptic Processing Using Single Use Technology
    Designer Sterile Filtration in Aseptic Processing Using Single Use Technology
    Alan Kelly, Project Engineer at Sanofi and Terri Love, Senior BioManufacturing at Merck Recorded: Nov 10 2020 94 mins
    Alan Kelly is a Project Engineer who has been employed within the pharma/biopharma industry in Ireland for the past 25 years and is currently in his 18th year at Sanofi Waterford. Previous employers include Leo Pharma and Elan. During his current tenure at Sanofi Alan has held several engineering roles, including Project Lead on two high speed aseptic vial-filling isolator technology lines integrated with industrial scale freeze dryers and as Process Engineering Manager during start-up of fill finish. Alan has worked in the Technical Services Department at Sanofi responsible for technical expertise input into front-end studies for new aseptic filling lines with isolator technology. In his most recent role in MSAT, Alan is responsible for next generation product transfers, identifying innovative technology including: real time microbial monitoring, drone vial studies to assess aseptic filling line set-ups and multi-purpose PAT technology for detection of trace silicone oil, leak detection and primary/secondary drying functionality for freeze dryers. Alan has successfully led cross functional teams in the qualification of high speed automatic visual inspection technology for cartridges and manual visual inspection of syringes. Alan has presented at international conferences including ISPE (Case study on VHP Cycle Development and Qualification of large scale aseptic Filling Isolator technology, European Compliance Agency (ECA) on “Case study on Manual Visual Inspection of syringes”, Alan is an active member of PDA Ireland Chapter and lead organiser for recent events including Annex 1 Conference (Revision of the EU GMP Guideline) May 2019 and Advances in Aseptic Processing with a focus on Media Fill simulations Oct 2018
  • Innovation in Biomanufacturing Plants
    Innovation in Biomanufacturing Plants
    Hang Zhou, Ph.D., Vice President at WuXi Biologics and Earl Pineda, Senior Manager, Field Applications, at Repligen, Europe Recorded: Nov 10 2020 91 mins
    Presented by Hang Zhou, Ph.D., Vice President, Head of Cell Culture Process Development Biologics and Bioprocess Dept. at WuXi Biologics

    Biopharmaceutical plants will look different in the future. Agility and flexibility for rapidly changing product portfolios, single-use technologies, continuous manufacturing, small batch manufacturing, personalised medicine manufacturing will not only change the face of a plant but will also require other logistics models. Chris will explain WuXi Biologics’ approach to biological facilities of the future.
  • Case Study: Biomanufacturing for Tomorrow
    Case Study: Biomanufacturing for Tomorrow
    Marc Pompiati, Principal Scientist at Roche Diagnostics GmbH Recorded: Nov 5 2020 52 mins
    ·Gain insight of a combined USP/DSP line (SUB + 1. column) using disposables and automated systems, and a connected process

    ·Uncover the link from early research to phase I to market manufacturing

    ·Understand why it is essential to address BM4T in early research and development
  • Bringing the Zero Trust Mindset to Data Protection
    Bringing the Zero Trust Mindset to Data Protection
    Nico Popp, Chief Product Officer, Forcepoint | Sean Sweeney, Chief Security Advisor, Microsoft Recorded: Nov 4 2020 36 mins
    The traditional approach to data security is increasingly inadequate. Old solutions introduce too much business friction, yet they still fall short when it comes to preventing data exfiltration. We need to approach data protection differently to make tools like DLP, encryption, and tokenization more responsive to the security needs of the decentralized, cloud-driven workplace.

    Introducing the core concepts of Zero Trust to your data protection posture ensures that all people in your organization are continuously being authenticated and authorized to have access to applications and data. A successful Zero Trust approach leverages dynamic, proactive, ongoing user risk assessment based on behavioral analytics to consistently prevent data breaches, while enhancing productivity rather than hindering it.

    In this session, you’ll learn more about bolstering data security with the Zero Trust mindset, including:
    - How Zero Trust and behavioral analytics can maximize the effectiveness of data protection solutions for increasingly mobile and remote workforces
    - How data security traveling with data (like fingerprinting) can help in today’s distributed environment
    - How security leaders are implementing these concepts in their environments and solutions
  • Improving diversity and inclusion in research and publishing
    Improving diversity and inclusion in research and publishing
    Dr Lan-Lan Smith, Editor-in-Chief of The Lancet Haematology Recorded: Nov 3 2020 71 mins
    Gender equity is not only a matter of justice and rights, it is crucial for producing the best research and providing the best care to patients. If the fields of science, medicine, and global health are to improve human lives, they must be representative of the societies they serve. The fight for gender equity is everyone’s responsibility: men and women, researchers, clinicians, funders, institutional leaders, and, yes, even medical journals.

    Join Dr Lan-Lan Smith, Editor-in-Chief of The Lancet Haematology, to learn about:
    • Why is gender equity important in research
    • What do statistics say about diversity and inclusion in publishing
    • What initiatives have been started at The Lancet to bridge the gap
  • Best Practices in Submitting Research for Highly Selective Journals
    Best Practices in Submitting Research for Highly Selective Journals
    Dr. Robert D. Eagling, Editor-in-Chief of Chem (Cell Press journal) Nov 29 2020 11:00 pm UTC 76 mins
    Learn techniques and strategies for publishing strategies to give you the best chance of successfully publishing in highly selective journals with Dr. Robert D. Eagling, editor-in-chief of Chem (a Cell Press journal). Dr. Eagling will share tips on developing your papers for premium publications (with special focus on researchers based in the Eastern Europe region), elaborate on his experience of working with researchers and authors throughout the research publishing cycle and discuss the opportunity to broadly disseminate findings. Dr. Eagling will also share more details about the growth of Cell Press journals in the physical sciences field. Such details will include the launch of many new titles, such as Chem, Matter, Joule, and One Earth. He’ll also outline Cell Press’s approach to high-demand, multi-disciplinary content and expanding OA publishing strategies at Cell Press. Join this engaging webinar and ask any remaining questions in the Q&A session. Don’t forget to extend this invitation to your colleagues who might find this of interest.

    About Robert Eagling:
    Robert Eagling, Ph.D., is a graduate of Newcastle University in England and brings to Chem around 15 years of experience in chemistry publishing. He came to Cell Press from the Royal Society for Chemistry (RSC), where he helped grow submissions and readership of Chemical Communications, increased the visibility and impact of Chemical Society Reviews in 10 years from 13 to 34, and led the launch of Chemical Science, the RSC’s flagship general chemistry journal with Professor David McMillan as the inaugural Editorial Board Chairman.
  • Learn how Lancet editors decide which papers to accept for publication
    Learn how Lancet editors decide which papers to accept for publication
    Heather Van Epps, Editor-in-Chief The Lancet Rheumatology Nov 30 2020 5:00 am UTC 69 mins
    Join Heather Van Epps, Editor-in-Chief of The Lancet Rheumatology, to learn about techniques and strategies for preparing your paper to submit to high-impact journals.

    Heather will share her experiences working with researchers and authors throughout the research publishing cycle. You will learn how to develop papers for submission to publications like the Lancet family of journals.

    Do not miss this engaging webinar―you are invited to join and ask any questions that you feel will benefit your research.

    Don't forget to download your manuscript checklist from the resources section.
  • Novel Technologies That Aid the Detection and Differentiation of Proteinaceous..
    Novel Technologies That Aid the Detection and Differentiation of Proteinaceous..
    Danny Chou, President and Founder at Compassion BioSolution, LLC Nov 30 2020 6:00 pm UTC 105 mins
    Full Title: Novel Technologies That Aid the Detection and Differentiation of Proteinaceous Impurities in Biologic Drug Substances and Drug Product

    Presented by Danny Chou, President and Founder at Compassion BioSolution, LLC

    The goal of this presentation is to share recent developments in analytical approaches to detect, quantify and differentiate impurities in biologics that are the result of protein-container, interaction and aggregation
  • How to Become a Successful Researcher At Every Stage of Your Career
    How to Become a Successful Researcher At Every Stage of Your Career
    Dr. Valentin Fuster, Editor-in-Chief, JACC & Dr. Harlan Krumholz, Cardiologist & Health Care Researcher at Yale University Nov 30 2020 10:00 pm UTC 90 mins
    Pursuing a career as a physician-scientist can be daunting, especially as the success rates for securing research grants has declined from 33% to 19%, while the number of grant applications has increased by 72%. However, the pathway can provide personal and professional fulfillment and dynamism, if the individual is equipped with a roadmap for success. Valentin Fuster, MD, PhD, MACC, editor in chief of the Journal of the American College of Cardiology (JACC), and Harlan M. Krumholz, MD, SM, FACC, director of the Yale Center for Outcomes Research and Evaluation at Yale School of Medicine, will discuss how to maintain a successful physician-scientist career at three stages: early career, mid-career and senior. They will include tips for grant receipts, the importance of the mentee/mentorship relationship, and the need for creativity in grant submissions. In addition, viewers will have the opportunity to ask these thought leaders questions and pointers.

    About the presenters:
    Dr. Valentin Fuster serves The Mount Sinai Hospital as Physician-in-Chief, as well as Director of Mount Sinai Heart, the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health. He is also the Richard Gorlin, MD/Heart Research Foundation Professor, Icahn School of Medicine at Mount Sinai.

    Dr. Harlan Krumholz is a cardiologist and health care researcher at Yale University and Yale New Haven Hospital. He also serves as Director of the Yale Center for Outcomes Research and Evaluation (CORE) at Yale School of Medicine.

    Learn more about the JACC family of journals at JACC.org.
  • Light/Matter Interactions: Illuminating Materials and Researchers
    Light/Matter Interactions: Illuminating Materials and Researchers
    Lea Nienhaus, Raffaella Buonsanti, and Bozhi Tian Dec 1 2020 4:00 am UTC 113 mins
    The interactions between light and matter have been widely studied for applications in energy, bioelectronics, and catalysis, among others. These applications are heavily reliant on precise synthesis and materials characterization in order to fundamentally understand the physics, chemistry, and biology that drive the observed phenomena.

    In this webinar, Lea Nienhaus, Raffaella Buonsanti, and Bozhi Tian discuss their efforts in studying light/matter interactions from different disciplinary backgrounds. In addition to their scientific insights, they will speak about their ongoing broader engagement with the scientific community and strong advocacy for mentoring, outreach, and science communication. Specifically, during a panel discussion, they will address how they have tried to keep engaged during this time away from the lab.

    About the speakers:

    Lea Nienhaus, Assistant Professor, Florida State University

    Lea Nienhaus obtained her PhD from the University of Illinois at Urbana-Champaign. Since 2018, the Nienhaus group has pioneered the application of bulk perovskite sensitizers in photon upconversion, and they are currently working on unraveling the complex photophysical processes occurring in these devices.

    Raffaella Buonsanti, Assistant Professor, EPFL

    Raffaella Buonsanti started her position as Tenure Track Assistant Professor at the Institute of Chemical Sciences and Engineering (ISIC) of the École Polytechnique Fédérale de Lausanne (EPFL) in November 2015. Through their core expertise in colloidal synthesis, her team develops novel approaches to creating complex materials to drive chemical transformations.

    Bozhi Tian, Associate Professor, University of Chicago

    Bozhi Tian received his Ph.D. degree in physical chemistry from Harvard University in 2010. He is currently an associate professor at the University of Chicago and working on semiconductor-enabled fundamental studies of subcellular biophysics and soft matter dynamics.
  • Content and Manuscript Submission Tips for JOGNN
    Content and Manuscript Submission Tips for JOGNN
    Dr. Patricia Robin McCartney, Associate Editor, Journal of Obstetric, Gynecologic & Neonatal Nursing Dec 1 2020 9:00 am UTC 47 mins
    Learn more about the Journal of Obstetric, Gynecologic & Neonatal Nursing from Dr. Patricia Robin McCartney, Associate Editor. In this engaging webinar, Dr. McCartney will share information about JOGNN, the JOGNN audience, and what to consider before submitting your manuscript for publication consideration in JOGNN. You will learn about the criteria for reporting clinical projects in manuscripts for the Health Care Improvement and Evaluation category. Dr. McCartney will also provide advice on preparing your manuscript, editorial style, the publishing process, and resources available to support authors.

    This webinar includes the opportunity to ask questions during the Q&A session. Don’t forget to extend the invite to your colleagues and friends who may find this of interest.

    About JOGNN (Journal of Obstetric, Gynecologic & Neonatal Nursing):
    JOGNN is an official journal of the Association of Women’s Health, Obstetric and Neonatal Nurses, and a premier resource to advance the health and health care of women, childbearing families, and newborns through the publication of peer-reviewed nursing and interdisciplinary scholarship. With a focus on nursing practice, JOGNN publishes the latest research, reviews, methods, clinical projects, practice issues, case reports, commentaries, resources for evidence-based practice, and policies related to the care of women, childbearing families, and newborns. This peer-reviewed scientific and technical journal is highly respected for groundbreaking articles on important - and sometimes controversial - issues. Articles published in JOGNN emphasize research evidence and clinical practice, building both science and clinical applications. JOGNN seeks research and clinical manuscripts on the evidence supporting current best practice as well as developing or emerging practice trends.
  • How to Prepare Your Manuscripts for Publication in Top Journals
    How to Prepare Your Manuscripts for Publication in Top Journals
    Kavitha Scranton, Ph.D., Senior Scientific Editor, Immunity (Cell Press) Dec 1 2020 11:00 pm UTC 78 mins
    Would you like to learn tips for writing and developing a strong narrative for your work? Do you want advice on how to prepare your manuscripts for publication in the best journal for your research? Join us for a webinar with Kavitha Scranton, Ph.D., Senior Scientific Editor at Immunity (Cell Press) to learn techniques and strategies to set yourself up for publishing success. Kavitha will share tips on developing your manuscript (with a special focus on researchers based in the Turkey/ME region), elaborate on her experience working with researchers throughout the publishing cycle, and highlight opportunities to broadly disseminate your research findings. Kavitha will also share more details about the growth of multidisciplinary Cell Press journals. Join this engaging webinar and get answers to your questions in the Q&A session. Don’t forget to extend this invitation to your colleagues who might find this of interest.

    About Kavitha Scranton:
    Kavitha Scranton received her Ph.D. in Immunology from the University of Massachusetts Medical School, where she studied the development and function of γδ T cells in the laboratory of Dr. Joonsoo Kang. She conducted her postdoctoral research at the Broad Institute of MIT and Harvard on T cell-mediated autoimmunity in the laboratory of Dr. Ramnik Xavier. In 2015, Kavitha joined Immunity as a scientific editor.
  • How to Publish with The Journal of Thoracic and Cardiovascular Surgery
    How to Publish with The Journal of Thoracic and Cardiovascular Surgery
    Richard D. Weisel, Editor, JTCVS, Y. Joseph Woo, Associate Editor, MD, Adult and Thomas A. D’Amico, MD, Thoracic Dec 2 2020 4:00 am UTC 55 mins
    Finding the right journal to publish your research and structuring your research to publish in premium journals can be a challenge. Learn techniques and strategies to publish in premium journals like the Journal of Thoracic and Cardiovascular Surgery (JTCVS) with Richard D. Weisel, Editor, JTCVS, Y. Joseph Woo, Associate Editor, MD, Adult and Thomas A. D’Amico, MD, Thoracic.

    You can expect to learn about:
    -Manuscript preparation tips
    -Features of successful manuscripts
    -Editorial process
    -How to publish in JTCVS
    -New Initiatives at the Journal

    Sign up for the free webinar workshop today and extend the invitation to your colleagues who may find this helpful.

    About Journal of Thoracic and Cardiovascular Surgery:
    The Journal of Thoracic and Cardiovascular Surgery presents original, peer-reviewed articles on diseases of the heart, great vessels, lungs and thorax with emphasis on surgical interventions. An official publication of The American Association for Thoracic Surgery and The Western Thoracic Surgical Association, the Journal focuses on techniques and developments in acquired cardiac surgery, congenital cardiac repair, thoracic procedures, heart and lung transplantation, mechanical circulatory support and other procedures.
  • Must Know Tips for Publishing in Premium Journals
    Must Know Tips for Publishing in Premium Journals
    Dr. Philip Earis, Editor-in-Chief, Joule, Cell Press Dec 2 2020 10:00 pm UTC 75 mins
    Join Dr. Philip Earis, Editor-in-Chief of Joule (Cell Press journal) for an engaging webinar to learn about techniques and strategies for authoring in high impact journals. Dr. Earis will present his experience working with researchers and authors throughout the research publishing cycle, how to develop papers for premium publications (with tips focused on researchers based in India), and the opportunity to broadly disseminate findings. Dr. Earis will talk to you about growth of Cell Press journals in the physical sciences field, which includes launch of many new titles such as Chem, Joule, Matter, and One Earth. He’ll also outline Cell Press’ approach to high-demand, multi-disciplinary content, and expanding OA publishing strategies at Cell Press. You won’t want to miss this informative webinar and how it can benefit your research process and impact. Please extend this invite to colleagues who may also find it of interest.

    More about Dr. Philip Earis:
    Philip is a graduate of Cambridge University in England and brings over 10 years of experience in publishing impactful energy research to Joule. He came to Cell Press after 3 years of living in India, where he founded and ran Project Light, an organization bringing solar power to marginalized off-grid communities in India. In this role, he worked closely with Indian and international scientists to develop and install appropriate solar energy technology.
  • Authoring in The Lancet — Learn from the Editors!
    Authoring in The Lancet — Learn from the Editors!
    John McConnell, Editor-in-Chief of The Lancet Infectious Diseases Dec 3 2020 5:00 am UTC 76 mins
    Join John McConnell, Editor-in-Chief of The Lancet Infectious Diseases to learn about techniques and strategies for authoring in high-impact journals. Mr. McConnell will present his experience working with researchers and authors throughout the research publishing cycle. You will learn how to develop papers for premium publications, and how to broadly disseminate findings. Do not miss this engaging webinar, join and ask any questions that you feel will benefit your research!
  • Best Practices in Submitting Research for Highly Selective Journals
    Best Practices in Submitting Research for Highly Selective Journals
    Dr. Robert D. Eagling, Editor-in-Chief of Chem (Cell Press journal) Dec 3 2020 9:00 am UTC 76 mins
    Learn techniques and strategies for publishing strategies to give you the best chance of successfully publishing in highly selective journals with Dr. Robert D. Eagling, editor-in-chief of Chem (a Cell Press journal). Dr. Eagling will share tips on developing your papers for premium publications (with special focus on researchers based in the Eastern Europe region), elaborate on his experience of working with researchers and authors throughout the research publishing cycle and discuss the opportunity to broadly disseminate findings. Dr. Eagling will also share more details about the growth of Cell Press journals in the physical sciences field. Such details will include the launch of many new titles, such as Chem, Matter, Joule, and One Earth. He’ll also outline Cell Press’s approach to high-demand, multi-disciplinary content and expanding OA publishing strategies at Cell Press. Join this engaging webinar and ask any remaining questions in the Q&A session. Don’t forget to extend this invitation to your colleagues who might find this of interest.

    About Robert Eagling:
    Robert Eagling, Ph.D., is a graduate of Newcastle University in England and brings to Chem around 15 years of experience in chemistry publishing. He came to Cell Press from the Royal Society for Chemistry (RSC), where he helped grow submissions and readership of Chemical Communications, increased the visibility and impact of Chemical Society Reviews in 10 years from 13 to 34, and led the launch of Chemical Science, the RSC’s flagship general chemistry journal with Professor David McMillan as the inaugural Editorial Board Chairman.
  • New Trends and Future Directions in Catalysis
    New Trends and Future Directions in Catalysis
    Frances Arnold, Lutz Ackermann, Corinna Schindler, and Douglas W. Stephan Dec 3 2020 11:00 pm UTC 107 mins
    The field of catalysis in chemistry was historically dominated by the use of transition metal catalysts. Due to a unique set of properties, precious metals in particular have played an integral role in developing catalysts for new modes of chemical bond activation and formation. One major and inherent drawback of precious metals, however, is their scarcity; in order to transition chemistry to a more sustainable use of the world’s limited resources, finding alternative strategies for catalysis is a major driving force in contemporary research. In this spirit, this webinar will feature talks about four areas of sustainable catalysis from leaders in their respective fields, highlighting state-of-the-art approaches and providing guidance for future developments in these areas of research.

    Speaker Information:

    Frances Arnold is Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry, and Director of the Donna and Benjamin M. Rosen Bioengineering Center at Caltech. She received the Nobel Prize in Chemistry in 2018 for directed enzyme evolution.

    Lutz Ackermann is a Professor at the Georg-August-University Göttingen. The development and application of novel concepts for sustainable catalysis constitutes his major current research interest, and he has a topical focus on C–H activation.

    Corinna Schindler is an Associate Professor at the University of Michigan. The research interests of her laboratory include the synthesis of complex molecules and the development of new synthetic transformations between carbonyls and alkenes.

    Douglas W. Stephan is a Professor at the University of Toronto and a world-leading researcher in inorganic chemistry/catalysis and the founder of the field of “frustrated Lewis pair” (FLP) chemistry. He has received many national and international awards, including Humboldt and Killam Fellowships.
  • Clinical Cases & Social Media: Tips & Techniques
    Clinical Cases & Social Media: Tips & Techniques
    Dr. Julia Grapsa, Editor-in-Chief, JACC: Case Reports & Dr. Mary Norine Walsh, MD, FACC, President, ACC Dec 4 2020 1:00 pm UTC 71 mins
    In order to create the right impact, researchers must first prepare their clinical case for successful submission and once published – work to ensure visibility of their findings for the benefit of the wider public. Join our webinar with Julia Grapsa, MD, PhD, FACC, editor-in-chief of JACC: Case Reports and Mary Norine Walsh, MD, MACC, deputy editor of JACC: Case Reports and past president of the ACC. You can expect to learn:
    • How to prepare a clinical case report
    • Common mistakes in submitting case reports
    • A checklist to follow prior to submission
    • Best practices to bring visibility to your research via social media
    • Benefits of each platform type and how you can use them to your advantage
    • How researchers can network online effectively

    Sign up for this engaging webinar and get an opportunity to find answers to your questions during the Q&A session with Dr. Grapsa & Dr. Walsh.

    About Dr. Grapsa:
    Julia Grapsa, MD, PhD, FACC, is a consultant cardiologist at Guys and St Thomas NHS Trust, where she is responsible for the valvular heart disease network and echocardiography. Prior to her role as JACC: Case Reports editor-in-chief, Dr. Grapsa served as an editorial consultant for JACC: Cardiovascular Imaging. Dr. Grapsa’s areas of research include valvular heart disease and the study of right heart remodelling.
    About Dr. Walsh:
    Mary Norine Walsh, MD, MACC is the medical director of the Heart Failure and Cardiac Transplantation Programs at St. Vincent Indianapolis Hospital; director of Nuclear Cardiology at The Care Group, a member of St. Vincent Medical Group; and clinical associate professor of Medicine at the Indiana University School of Medicine. Her areas of expertise include nuclear cardiology, congestive heart failure and cardiac transplantation with a special interest in women and heart disease.
  • How to publish in groundbreaking journals
    How to publish in groundbreaking journals
    Steve W. Cranford, Editor-in-Chief, Matter Dec 4 2020 11:00 pm UTC 87 mins
    Would you like to learn tips for writing and developing a strong narrative for your work? Do you want advice on how to prepare your manuscripts for publication in the best journal for your research? Join us for a webinar with Steve W. Cranford, Editor-in-Chief, Matter to learn techniques and strategies to set yourself up for publishing success. Dr. Cranford will share details about the growth of multidisciplinary Cell Press journals and tips on developing your manuscript and will elaborate on his experience working with researchers throughout the publishing cycle. Join this engaging webinar and get answers to your questions in the Q&A session. Don’t forget to extend this invitation to your colleagues who might find this of interest.

    About Steve W. Cranford:
    A graduate from Memorial University (Canada), Stanford University (USA), and Massachusetts Institute of Technology (USA), Dr. Cranford was faculty at Northeastern University’s College of Engineering prior to accepting a new role as editor-in-chief for Matter.
    He has over 50 publications in the field of materials science in a range of high-impact journals, including Nature and Advanced Materials, with expertise in the area of atomistic simulation, computational modeling, and nanomechanics, encompassing a variety of materials systems, from carbyne to copper to concrete.
    He would have preferred to have published in Matter, but it didn’t exist. He constantly played with LEGO blocks as a child, likely leading to his interest in material assembly and structure.

    About the journal Matter:
    Matter, a sister journal to Cell, is a monthly journal encompassing the general field of materials science, from nano to macro and fundamentals to application. Recognizing that materials discovery and development facilitate groundbreaking technologies bridging multiple disciplines, Matter will embrace all significant advances in materials research, encompassing the previously unknown and the innovative.
  • Techniques for Publishing in Transformative Ground-Breaking Journals
    Techniques for Publishing in Transformative Ground-Breaking Journals
    Dr. Lewis Collins, Editor-in-Chief, One Earth (A Cell Press journal) Dec 5 2020 3:00 am UTC 75 mins
    Learn techniques and strategies for publishing in transformative ground-breaking journals with Dr. Lewis Collins, Editor-in-Chief of One Earth (a Cell Press journal). Dr. Collins will share tips on developing your papers for ground-breaking publications, elaborate on his experience of working with researchers and authors throughout the research publishing cycle and the opportunity to broadly disseminate findings. Dr. Collins will also share more details about the growth of Cell Press journals in the physical and environmental sciences field, including the launch of many new titles such as Chem, Matter, Joule, and One Earth. He’ll outline Cell Press’ approach to high-demand, multi-disciplinary content, and expanding OA publishing strategies at Cell Press. Join this engaging webinar to find the answers to your pressing questions in the Q&A session during the webinar. Don’t forget to extend this invite to your colleagues who might find this of interest.

    About Lewis Collins:
    Inspired by David Attenborough documentaries as a child, Lewis has been amazed by the natural world from an early age. While undergraduate and master’s degrees in Earth science (Cardiff University), and Climate Change (University of East Anglia) nurtured this interest, it was doctoral (British Antarctic Survey) and post-doctoral (Université Pierre et Marie Curie) research on Antarctica that centered his focus on environmental change. Prior to launching One Earth, Lewis spent over 5 years with Nature Communications, where he led the Earth editorial team and curated, commissioned, handled (and occasionally rejected…) research across the full spectrum of Earth and environmental science. Lewis is particularly interested in grand challenges associated with land-use and the competing demands for this increasingly scarce resource.
  • How to Publish with The Journal of Thoracic and Cardiovascular Surgery
    How to Publish with The Journal of Thoracic and Cardiovascular Surgery
    Richard D. Weisel, Editor, JTCVS, Y. Joseph Woo, Associate Editor, MD, Adult and Thomas A. D’Amico, MD, Thoracic Dec 8 2020 7:30 am UTC 55 mins
    Finding the right journal to publish your research and structuring your research to publish in premium journals can be a challenge. Learn techniques and strategies to publish in premium journals like the Journal of Thoracic and Cardiovascular Surgery (JTCVS) with Richard D. Weisel, Editor, JTCVS, Y. Joseph Woo, Associate Editor, MD, Adult and Thomas A. D’Amico, MD, Thoracic.

    You can expect to learn about:
    -Manuscript preparation tips
    -Features of successful manuscripts
    -Editorial process
    -How to publish in JTCVS
    -New Initiatives at the Journal

    Sign up for the free webinar workshop today and extend the invitation to your colleagues who may find this helpful.

    About Journal of Thoracic and Cardiovascular Surgery:
    The Journal of Thoracic and Cardiovascular Surgery presents original, peer-reviewed articles on diseases of the heart, great vessels, lungs and thorax with emphasis on surgical interventions. An official publication of The American Association for Thoracic Surgery and The Western Thoracic Surgical Association, the Journal focuses on techniques and developments in acquired cardiac surgery, congenital cardiac repair, thoracic procedures, heart and lung transplantation, mechanical circulatory support and other procedures.
  • Making the Most of Data Loss Prevention Technology
    Making the Most of Data Loss Prevention Technology
    Carl Eberling, CIO, Forcepoint | Eric Jackson, Vice President, General Manager User & Data Protection, Forcepoint Dec 8 2020 9:00 am UTC 34 mins
    Data Loss Prevention (DLP) technology has been with us for many years and is now part of the common security defences employed by organizations. But today’s Enterprise DLP is anything but standard, having evolved many new and advanced capabilities that put it at the heart of a data protection strategy.

    In this discussion we examine:
    - How these new functionalities can help us address the challenges of the new working landscape
    - How to accelerate your strategy and re-think what is possible
  • Introducing the inter-disciplinary journal Chem & tips for publishing in Chem
    Introducing the inter-disciplinary journal Chem & tips for publishing in Chem
    Dr. Robert Eagling, Editor-in-Chief of Chem (Cell Press journal) Jan 21 2021 8:00 am UTC 90 mins
    Introducing Chem (launched July, 2017), a sister journal to Cell, which provides a home for seminal and insightful research and showcases how fundamental studies in chemistry and its sub-disciplines may help in finding potential solutions to the global challenges of tomorrow. Chem had the first year impact factor of 14.1 (2019) and second year impact factor of 19.735 (2020) and also won the PROSE excellence award in Physical Sciences & Mathematics. Chem publishes work from across the chemical sciences and at the interfaces between chemistry and other disciplines. On submission, authors are asked to categorize their article into at least one of the following ten Sustainable Development Goals identified by the United Nations.
    Join Dr. Robert Eagling, Editor-in-Chief, Chem in an engaging webinar as he introduces the new journal Chem, talks about what makes Chem unique, explores why you should read and publish with the inter-disciplinary journal Chem and shares techniques and strategies for researchers based in Japan on publishing with Chem.
    About Robert Eagling:
    Robert Eagling, Ph.D., is a graduate of Newcastle University in England and brings to Chem around 15 years of experience in chemistry publishing. He came to Cell Press from the Royal Society for Chemistry (RSC), where he helped grow submissions and readership of Chemical Communications, increased the visibility and impact of Chemical Society Reviews in 10 years from 13 to 34, and led the launch of Chemical Science, the RSC’s flagship general chemistry journal with Professor David McMillan as the inaugural Editorial Board Chairman.
  • How can you Best Use Network Analytics and Modelling To Support Digital...
    How can you Best Use Network Analytics and Modelling To Support Digital...
    Presented by Gareth Alford, Lead Engineer at GSK and Bob Lenich, Director of Life Sciences Business at Emerson Feb 1 2021 3:00 pm UTC 120 mins
    Full title: How can you Best Use Network Analytics and Modelling To Support Digital Engineering In Pharma Manufacturing Operations

    Using the development of continuous manufacturing modules as a platform to look at the opportunities that arise through digitalization. The modular continuous manufacturing approach has allowed the detailed development of reproducible digital assets. These have in turn allowed the development of process models, mechanistic and statistical, to sit along side the process development through to manufacturing. The discussion today will look at discussing the challenges, both technical and cultural, and the opportunities that exist both now, and down the line as we build upon the experiences. We will concentrate on the benefits associated with the continuous platform, although the approach is applicable in a wider context, albeit with different technical challenges. Some areas that we will look to explore through the discussions will include the use of the models as part of regulatory filing, the use of the platform as an open source engineering set to build adoption, and how digitalization of our process understanding changes the fabric of the facilities that we operate.
  • Continuous Capture and Continuous Recovery - Novel Ideas for Product Recovery..
    Continuous Capture and Continuous Recovery - Novel Ideas for Product Recovery..
    Kerstin Lange and Andrew Falconbridge at Alvotech Feb 3 2021 3:00 pm UTC 105 mins
    Alvotech developed an intensified fed-batch process using a cell retention device for the production of a complex fusion protein. The process uses the novel technique of High Productivity Harvest (HPH), which involves a traditional FB process and a clarification process using a cell retention device. Implementing the new process resulted in higher vcd and viability, improved product quality, and a reduction of cost of manufacture compared to the conventional fed-batch process.

    Alvotech developed an intensified fed-batch process using a cell retention device for the production of a complex fusion protein. The process uses the novel technique of High Productivity Harvest (HPH), which involves a traditional FB process and a clarification process using a cell retention device. Implementing the new process resulted in higher vcd and viability, improved product quality, and a reduction of cost of manufacture compared to the conventional fed-batch process.
  • Changing the Paradigm:  Moving to In-Process Release Testing
    Changing the Paradigm: Moving to In-Process Release Testing
    Presented by Scott Weiss, Johnson & Johnson and Lori Daane at bioMérieux Feb 5 2021 3:00 pm UTC 120 mins
    Changing the paradigm – moving to in-process release testing is a presentation to explore the possibilities of the future.  We will discuss limitations of traditional methods of monitoring and release, and investigate the existing challenges of current rapid method technologies.  What are we missing?  If we change our way of thinking around the acceptable limitations of traditional methods and look to the future with existing technologies and those on the horizon, using an end-to-end mindset, we can build the better mouse trap within our processes.  We can identify key markers with real time monitoring, using big data, so that by the end of the manufacturing process there is no need for final product microbiological quality testing.
  • Future Trends To Control Risks From Extractables and Leachables
    Future Trends To Control Risks From Extractables and Leachables
    Presented by Jason Creasey, Managing Director at Maven E&L Ltd Feb 9 2021 3:00 pm UTC 105 mins
    Presented by Jason Creasey, Managing Director at Maven E&L Ltd

    Jason Creasey is a graduate Analytical Chemist. He has recently setup as an independent consultant providing advice in the area of extractables and leachables, after working for GSK in the area of extractables and leachables since the mid 1990’s.

    Over that time, he has seen demand in this area grow exponentially and Jason has held roles of increasing seniority relating to the support that GSK has given to extractables and leachables (E&L). Before setting up Maven E&L Ltd, he was the director of a team of analytical chemists who are responsible for GSK’s global R&D support for E&L activities across a wide range of product types and modalities. This included; biopharmaceutical and small molecules including Inhalation, Parenteral and Cell & Gene Therapy use. He has had the pleasure of commenting on PQRI guidelines on E&L for GSK, the E&L section in EMEA guidelines on inhalation and nasal products and co-authoring a chapter within a book entitled “Leachables and Extractables Handbook: Safety Evaluation, Qualification, and Best Practices Applied to Inhalation Drug Products”.

    Jason has been a member of several external groups concerned with the development of best practice guides for extractable and leachables issues these include; the IPAC-RS material working group, BPOG and continues as a scientific advisor to Extractable and Leachable Safety Information Exchange otherwise known as ELSIE. Currently he is working and commenting on risk- based approaches to E&L requirements, which he hopes will form part of an ICH guidance in the not too distant future.
  • Process Development & Manufacturing Technologies for Bio-therapeutics...
    Process Development & Manufacturing Technologies for Bio-therapeutics...
    Atin Tomar, and Nirav Desai at Yapan Bio Mar 3 2021 9:30 am UTC 120 mins
    Full Title: Process Development & Manufacturing Technologies for Bio-therapeutics and Vaccines

    Presented by Atin Tomar, Co-Founder & CEO at Yapan Bio and Nirav Desai, Co-Founder at Yapan Bio
  • A Data Driven Biopharmaceutical Manufacturing Facility-Plug and Produce...
    A Data Driven Biopharmaceutical Manufacturing Facility-Plug and Produce...
    Presented by Josef Trapl Global Manufacturing & Supply, Head of MSci Innovation Mar 4 2021 3:00 pm UTC 120 mins
    Full Title: A Data Driven Biopharmaceutical Manufacturing Facility-Plug and Produce -Shaping the Future Together

    With the high priority buzzwords “Industry 4.0” and the “IIoT” (Industrial Internet of Things) the Biopharma industry amongst the other partners in the Life Science / Healthcare industry strives toward a future purely data driven research, development, manufacturing and supply. From a technological perspective everything seems to be possible and in place starting from IaaS, SaaS, PaaS etc. up to the usage of 5G and associated devices. This means shop floor machinery and lab equipment will be connected plug & play like the printer at home and a bi-directional communication with real time data exchange to other software systems will be in place right first time when starting the production. Related business processes can be automated and data analyzed at any time at any place.  

    The reality looks different and a lot of companies are in the phase to build the foundation for a potential future scalable digital (IT/OT) platform. There are a lot of challenges where a good guideline is the maturity model which shows you exactly the “Status Quo” of your existing brownfield or new greenfield bioproduction facility. The Webinar will help you in a common discussion to understand the current challenges and how to materialize opportunities towards our digital Biopharma industry journey.
  • Demonstrate how machine learning tools can aid development of formulation...
    Demonstrate how machine learning tools can aid development of formulation...
    Rolf Taaning, Development Specialist PhD, and Erik Skibsted, Principal Scientist PhD at Novo Nordisk Denmark Mar 8 2021 3:00 pm UTC 120 mins
    Full Title: Demonstrate how machine learning tools can aid development of formulation, analysis and manufacturing of pharmaceutical drug products

    Novo Nordisk has initiated several optimisation projects using machine learning tools and robotics as alternatives to traditional design of experiments (DoE) methodologies and hands-on experiments. The reasoning is a pursuit to find better optima using fewer resources. In this webinar Rolf Hejle Taaning and Erik Skibsted from Novo Nordisk will demonstrate optimisation of pharmaceutical liquid formulations and chemical reactions using a mix of different tools like Bayesian Optimisation, Principal Component Analysis and Robotics.